German Stemmelin
British Hospital
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by German Stemmelin.
Revista Medica De Chile | 2015
Pablo Young; María Massa; Bárbara C Finn; Gonzalo Fleire; German Stemmelin; Amanda Ruades; Daniel Sutovsky; José G. Casas; Pablo Dezanzo; Félix Vigovich; Julio E Bruetman
Intravascular lymphoma is a rare subtype of extranodal diffuse large B-cell lymphoma characterized by clonal proliferation of lymphocytes inside of small and medium caliber vessels. Its incidence is estimated at one case per million. The clinical picture is very variable, but frequently has skin and central nervous system involvement. It is diagnosed by demonstrating pathological blood vessel infiltration by lymphoma cells. We report a 44 years old male presenting with fever, malaise and erythematous lesions in the abdominal wall. An abdominal wall biopsy showed dilated vascular vessels with atypical cells in their lumen, compatible with large B-cell intravascular lymphoma. He was treated with rituximab, cyclophosphamide, adriamycin, vincristine and prednisone and an autologous hematopoietic stem cell transplantation, achieving a complete remission that has lasted two years.
Revista Medica De Chile | 2013
Hernán Trimarchi; Fernando Lombi; Mariano Forrester; Vanesa Pomeranz; Oscar Rabinovich; German Stemmelin; Pablo Ruiz; Alejandro Iotti; Pablo Young
Idiopathic Light Chain disease (ILCD) is a systemic disease characterized by a deposit in different organs of light chain monoclonal immunoglobulins, produced by an abnormal clone ofB cells. It is usually found in the course ofa plasma cell dyscrasia and in other lymphoproliferative alterations; however it may occur in absence of any hematologic disease and is denominated as idiopathic. We report a 51-year-old mole admitted to the hospital due to anasarca. Laboratory evaluation showed a serum creatinine of 1.4 mg/dl, a serum albumin of1.6 g/dl, a serum cholesterol of 687 mg/dl and a proteinuria of 5.3 g/day Light chains with a predominance of a monoclonal component were identified in urinary proteins by electrophoresis and kappa chains were identified by immunofixation. A renal biopsy showed a diffuse nodular glomerulopathy with a 35% tubular atrophy and interstitial sclerosis. Electron microscopy confirmed light chain deposition. The bone marrow biopsy showed a myeloid hyperplasia. Thepatient was initially treated with methylprednisolone and plasmapheresis with a reduction in serum creatinine and disappearance of urinary kappa component. Albuminuriapersisted and a malnutrition-inflammatory complex syndrome was diagnosed. Hemodialysis with ultrafiltration was started along with cyclophosphamide. Thepatient receivedhemodialysisforsixmonths and continued with methylprednisolone.Idiopathic Light Chain disease (ILCD) is a systemic disease characterized by a deposit in different organs of light chain monoclonal immunoglobulins, produced by an abnormal clone of B cells. It is usually found in the course ofa plasma cell dyscrasia and in other lymphoproliferative alterations; however it may occur in absence of any hematologic disease and is denominated as idiopathic. We report a 51-year-old mole admitted to the hospital due to anasarca. Laboratory evaluation showed a serum creatinine of 1.4 mg/dl, a serum albumin of1.6 g/dl, a serum cholesterol of 687 mg/dl and a proteinuria of 5.3 g/day Light chains with a predominance of a monoclonal component were identified in urinary proteins by electrophoresis and kappa chains were identified by immunofixation. A renal biopsy showed a diffuse nodular glomerulopathy with a 35% tubular atrophy and interstitial sclerosis. Electrón microscopy confirmed light chain deposition. The bone marrow biopsy showed a myeloid hyperplasia. The patient was initially treated with methylprednisolone and plasmapheresis with a reduction in serum creatinine and disappearance of urinary kappa component. Albuminuria persisted and a malnutrition-inflammatory complex syndrome was diagnosed. Hemodialysis with ultrafiltration was started along with cyclophosphamide. The patient received hemodialysis for six months and continued with methylprednisolone.
Blood | 2005
Alejandro Schamun; Eduardo Bullorsky; German Stemmelin; Ricardo Saxton; Daniel Ricchione
Blood | 2007
Carlos Doti; German Stemmelin; Claudia Shanley; José Ceresetto; Oscar Rabinovich; Beatriz Moiraghi; María Gabriela Flores; Juan José García García; Eduardo Bullorsky
Journal of Clinical Apheresis | 1994
L. Bik To; German Stemmelin; David N. Haylock; Joanne L. Bayly; Dawn Thorp; Caroline M. Rawling; Sandra Trimboli; Christopher A. Juttner
Blood | 2006
R. Fernando Bezares; German Stemmelin; Daniel Argentieri; Emilio Lanari; Efrain Guy-Garay; Reinaldo Campestri; Miguel Bartomioli; Juan José García García; Sergio Giralt; Gustav Milone
Blood | 2004
German Stemmelin; Carlos Doti; Claudia Shanley; José Ceresetto; Oscar Rabinovich; Maria A. Vicente Reparaz; Matias Vukovic; Eduardo Bullorsky
Medicina-buenos Aires | 2002
Eduardo Bullorsky; Claudia Shanley; German Stemmelin; José Ceresetto; Oscar Rabinovich
Medicina-buenos Aires | 2017
Marta Martinuzzo; Cristina Duboscq; Estela Vinuales; Beatriz Girardi; Diana Penchasky; José Ceresetto; German Stemmelin; Victoria Otero; Luis Barrera; Marina Sol López; Juan Carlos Otaso; José Oyhamburu
Acta Bioquimica Clinica Latinoamericana | 2016
Cristina Duboscq; José Ceresetto; Claudia Shanley; Oscar Ravinovich; Silvina Palmer; German Stemmelin